Pallas Capital Advisors LLC Sells 474 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Pallas Capital Advisors LLC trimmed its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 44.3% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 596 shares of the company’s stock after selling 474 shares during the period. Pallas Capital Advisors LLC’s holdings in HCA Healthcare were worth $238,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in the business. Capital World Investors raised its position in shares of HCA Healthcare by 57.5% in the first quarter. Capital World Investors now owns 2,792,377 shares of the company’s stock valued at $931,342,000 after purchasing an additional 1,019,750 shares during the period. Lee Danner & Bass Inc. bought a new stake in shares of HCA Healthcare during the second quarter worth approximately $131,527,000. Darsana Capital Partners LP increased its stake in shares of HCA Healthcare by 53.3% during the second quarter. Darsana Capital Partners LP now owns 1,150,000 shares of the company’s stock worth $369,472,000 after purchasing an additional 400,000 shares during the period. Swedbank AB acquired a new position in HCA Healthcare in the 1st quarter valued at $95,882,000. Finally, TD Asset Management Inc lifted its holdings in shares of HCA Healthcare by 30.4% during the first quarter. TD Asset Management Inc now owns 721,318 shares of the company’s stock worth $240,581,000 after buying an additional 168,093 shares in the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.

HCA Healthcare Stock Performance

HCA Healthcare stock opened at $357.19 on Friday. HCA Healthcare, Inc. has a 1 year low of $225.32 and a 1 year high of $417.14. The company has a debt-to-equity ratio of 48.71, a current ratio of 1.12 and a quick ratio of 1.00. The company has a market capitalization of $92.18 billion, a P/E ratio of 16.04, a P/E/G ratio of 1.38 and a beta of 1.67. The business has a 50 day moving average of $392.99 and a 200-day moving average of $354.17.

HCA Healthcare Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Friday, December 13th will be issued a $0.66 dividend. The ex-dividend date of this dividend is Friday, December 13th. This represents a $2.64 annualized dividend and a yield of 0.74%. HCA Healthcare’s payout ratio is 11.85%.

Insiders Place Their Bets

In related news, EVP Michael S. Cuffe sold 8,358 shares of the firm’s stock in a transaction that occurred on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the completion of the sale, the executive vice president now owns 29,678 shares of the company’s stock, valued at $11,438,494.76. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Company insiders own 1.60% of the company’s stock.

Analyst Ratings Changes

Several analysts have weighed in on the stock. Royal Bank of Canada lifted their price objective on shares of HCA Healthcare from $378.00 to $405.00 and gave the stock an “outperform” rating in a research note on Friday, August 23rd. Cantor Fitzgerald reissued an “overweight” rating and set a $392.00 price target on shares of HCA Healthcare in a research report on Tuesday, October 1st. Barclays increased their target price on HCA Healthcare from $376.00 to $396.00 and gave the stock an “overweight” rating in a report on Wednesday, July 24th. Truist Financial upped their price objective on shares of HCA Healthcare from $390.00 to $430.00 and gave the stock a “buy” rating in a research report on Monday, August 19th. Finally, TD Cowen cut their price target on shares of HCA Healthcare from $450.00 to $440.00 and set a “buy” rating for the company in a report on Monday, October 28th. Five analysts have rated the stock with a hold rating, thirteen have issued a buy rating and three have issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $379.11.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.